Skip to content
Back to Guavy Wire
Stocks

Salesforce Gets Boost from Guggenheim Analysts

Instruments
CRM
Share

Salesforce (NYSE:CRM) has had its 'buy' rating reaffirmed by equities researchers at Guggenheim in a research note issued on Thursday.

Guggenheim currently has a target price of $228.00 on the CRM provider's stock, indicating a potential upside of 10.68% from the current price of $206.00.

This is not the only positive view on Salesforce from analysts in recent weeks. Citigroup recently upped their price objective on shares of Salesforce from $187.00 to $204.00 and gave the stock a 'neutral' rating.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc